它是口服有效的Eprodisate二钠盐形式, 是一种带负电荷的磺化类的原纤维形成抑制剂剂, 用于治疗淀粉样蛋白A (AA) 淀粉样变性病。Reactant involved in synthesis of: . Cadmium(II) bipyridine complex metal-organic frameworks with alkanedisulfonates . Alkylenedisulfonate inorganic-organic hybrid materials Glycosaminoglycan mimetic involved in pharmacological studies for the treatment of amyloid A amyloidosis
It is the orally available disodium salt form of Eprodisate, a negatively charged sulfonated inhibitor of fibrillogenesis, that can be used in the treatment of amyloid A (AA) amyloidosis. Reactant involved in synthesis of: . Cadmium(II) bipyridine complex metal-organic frameworks with alkanedisulfonates . Alkylenedisulfonate inorganic-organic hybrid materials Glycosaminoglycan mimetic involved in pharmacological studies for the treatment of amyloid A amyloidosis
Reactant involved in synthesis of:
. Cadmium(II) bipyridine complex metal-organic frameworks with alkanedisulfonates
. Alkylenedisulfonate inorganic-organic hybrid materials
Glycosaminoglycan mimetic involved in pharmacological studies for the treatment of amyloid A amyloidosis